Furthermore, a treatment with a miR-16-5p mimic demonstrated that this miRNA could induce apoptosis and reduce the viability of prostate cancer cells by targeting a key target gene associated with carcinogenesis, i.e., AKT3 [47]. The gene discussed is AKT3; the disease is prostate carcinoma.